Translational Oncology Council
About Translational Oncology Council
Data last updated:
Translational Oncology Council is a private not for profit company based in Visakhapatnam, Andhra Pradesh, India. It operates in the social services and community development segment of the non-profit sector. It was incorporated on 05 October 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U85300AP2020NPL115951.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10,000. It is led by directors including Hima Bindu Gaddipati and Pallavi Purushottam Joshi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Dr.No.9&12 S No.119 Maharanipet, Visakhapatnam, Andhra Pradesh, India – 530002.
As per the financials filed for FY 2022, the company reported a revenue of ₹1.32 Lakh. For the same year it recorded a net loss of ₹19.49 Lakh and EBITDA of -₹13.35 Lakh.
Company details
Contact details
Translational Oncology Council's registered office is in Visakhapatnam, Andhra Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressDr.No.9&12 S No.119 Maharanipet, Visakhapatnam, Andhra Pradesh, India – 530002
- IndustryNon-Profit Organizations, Social Work
To see the full contact details of Translational Oncology Council, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Translational Oncology Council
FY 2025 filings availableTranslational Oncology Council reported revenue of ₹1.32 Lakh for FY 2022.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ₹1.32 Lakh | |
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | -₹13.35 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | -₹19.49 Lakh | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | ||
| Net Profit Margin | ||
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Translational Oncology Council, buy the company report.
Board of directors of Translational Oncology Council
Translational Oncology Council has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Hima Bindu Gaddipati Also directs: Skmahi Healthcare Private Limited, Innohub Infra Development Private Limited, Eliczen Lifesciences Private Limited and 2 more | Director | 13 Jun 2024 | 2 Years 4 Months | Current |
| Pallavi Purushottam Joshi | Director | 05 Oct 2020 | 6 Years 0 Months | Current |
| Gaddipati Kishore Venkatasiva Also directs: Innohub Infra Development Private Limited | Director | 13 Aug 2024 | 2 Years 2 Months | Current |
| Mandar Vivekanand Kulkarni Also directs: Skmahi Healthcare Private Limited, Innohub Infra Development Private Limited, Eliczen Lifesciences Private Limited and 3 more | Director | 05 Oct 2020 | 6 Years 0 Months | Current |
Auditor
Translational Oncology Council is audited by S T MOHITE & CO for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S T MOHITE & CO | FY 2022 | 011410S |
Shareholding
The shareholding of Translational Oncology Council is on record for 2 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Translational Oncology Council, buy the company report.
Legal cases
No court or tribunal cases involving Translational Oncology Council are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Translational Oncology Council; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Translational Oncology Council has 1 active EPFO establishment as of Apr 07, 2024.
GST
No GST registration is on our record for Translational Oncology Council; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Translational Oncology Council has 6 board changes on record since 2020: 4 appointments and 2 cessations. The latest: Gaddipati Kishore Venkatasiva ceased to be Additional Director on 29 Sep 2024.
Frequently asked questions
Translational Oncology Council is an active private not for profit company based in Visakhapatnam, Andhra Pradesh, India. The company works in social work, within the non-profit organizations industry. It was incorporated on 05 October 2020 (6+ years old) and is registered under CIN U85300AP2020NPL115951.
Translational Oncology Council has 4 current directors:
- Hima Bindu Gaddipati - Director
- Pallavi Purushottam Joshi - Director
- Gaddipati Kishore Venkatasiva - Director
- Mandar Vivekanand Kulkarni - Director
The latest financial statements of Translational Oncology Council on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Translational Oncology Council is U85300AP2020NPL115951. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Translational Oncology Council was incorporated on 05 October 2020, making it 6+ years old. It is registered with the Registrar of Companies, Vijayawada.
Gaddipati Kishore Venkatasiva ceased to be Additional Director on 29 Sep 2024. Hima Bindu Gaddipati ceased to be Additional Director on 29 Sep 2024. Gaddipati Kishore Venkatasiva was appointed as Director on 13 Aug 2024. Translational Oncology Council has 6 board changes on record in total.
The registered office of Translational Oncology Council is at Dr.No.9&12 S No.119 Maharanipet, Visakhapatnam, Andhra Pradesh, India – 530002.
Translational Oncology Council operates in the non-profit organizations industry, in the social work segment.
Translational Oncology Council can be reached at its registered office: Dr.No.9&12 S No.119 Maharanipet, Visakhapatnam, Andhra Pradesh, India – 530002.
Translational Oncology Council is registered under the jurisdiction of the Registrar of Companies (ROC), Vijayawada.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
